Trial of Perioperative Endocrine Therapy - Individualising Care.

Trial Profile

Trial of Perioperative Endocrine Therapy - Individualising Care.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Dec 2016

At a glance

  • Drugs Anastrozole (Primary) ; Letrozole (Primary) ; Antineoplastics
  • Indications Early breast cancer
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Acronyms POETIC
  • Most Recent Events

    • 20 Oct 2013 Accrual to date is 98% according to United Kingdom Clinical Research Network.
    • 15 Oct 2013 Accrual to date is 97% according to United Kingdom Clinical Research Network.
    • 15 Oct 2013 Planned number of patients changed from 5200 to 5400 as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top